首頁 > 市場調查報告書 > 材料

有機化合物

市場調查報告書

商品編碼

1512688

全球磷脂質市場 - 2024-2031

Global Phospholipids Market - 2024-2031

出版日期: 2024年07月10日 | 出版商:

DataM Intelligence | 英文 243 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年全球磷脂市場規模達29.7億美元，預計2031年將達到51.3億美元，2024-2031年預測期間複合年成長率為7.03%。

磷脂因其獨特的性質和功能而成為具有多種應用的重要成分。它們可以來自大豆、向日葵、雞蛋等，並且有多種類型，包括磷脂醯絲氨酸和磷脂醯膽鹼。磷脂因其各種促進健康的特性而受到認可，包括心血管健康、認知功能支持和皮膚健康改善。

磷脂具有一系列功能，因此可應用於各個行業，包括食品和飲料、營養補充劑和藥品，以及其他領域的其他應用。消費者意識的不斷增強正在推動多個行業採用磷脂質並促進市場成長。

北美主導全球市場。該地區患有心臟病和糖尿病等慢性疾病。根據美國疾病管制與預防中心的數據，2021 年美國有8.9% 的人口被診斷出患有糖尿病此外，2021 年美國約有695,000 人死於心臟病。中發揮著至關重要的作用並提高生物利用度，推動其在區域市場的需求。

動力學

製藥和保健品產業對磷脂質的需求不斷成長

隨著心臟病和糖尿病等慢性疾病變得越來越普遍，對有效治療的需求也增加。人們對保持身體健康和創造營養保健品和藥品市場更感興趣。人們對預防性醫療保健的日益關注刺激了對含有磷脂的藥物和營養產品的需求，磷脂被認為對整體健康有益。

磷脂有助於藥物更好地被人體吸收，使其更有效。許多藥物難溶於水。磷脂不能很好地固定某些藥物的溶解度，從而實現更好的遞送。隨著製藥和營養保健品產業在全球範圍內不斷擴張，對磷脂質的需求預計將大幅成長。

新品發布

引入市場的新產品和技術增加了磷脂在各種最終用途應用中的探索和利用，並提供了新的和可用的實用選項，擴大了市場成長。例如，2024年5月，Vitafoods Europe推出了MPL+，這是一種海洋磷脂細胞營養和創新產品。 MPL+ 技術平台利用磷脂質作為獨特輸送平台的潛力，為營養保健品產業帶來創新。

同樣，2022年11月，Aker BioMarine推出了新的PL+技術平台，利用磷蝦中的磷脂來提高生物利用度或吸收率較差的成分的溶解度和乳化性。 PL+ 技術封裝在軟凝膠中，其中含有大麻二酚、薑黃素等具有挑戰性的成分。根據 Aker BioMarine 的說法，PL+ 可以將吸收提高多達 25 倍。

與磷脂相關的高成本

全球磷脂市場的主要阻礙因素之一是生產和提取過程的高成本。磷脂質並不容易從大豆或雞蛋等天然來源中取得。這些複雜的萃取技術需要昂貴的設備、先進的技術和熟練的勞動力。高效提取依賴複雜的技術，從而增加了整體成本。

此外，原物料波動也會加劇價格上漲。大豆、雞蛋或葵花籽（磷脂質的主要來源）的成本可能會發生顯著變化。這種不穩定性使生產商難以預測和管理其整體定價。這可能會阻礙公司進入市場並限制消費者對磷脂質產品的承受能力。

Phospholipids are essential components with diverse applications due to their unique properties and functions. They can be sourced from soybeans, sunflowers, eggs and others and come in various types, including phosphatidylserine and phosphatidylcholine. Phospholipids are recognised for their various health-promoting properties, including cardiovascular health, cognitive function support and skin health improvement.

Phospholipids offer a range of functionalities, due to which they find applications in various industries including food and beverages, nutraceutical supplements, and pharmaceuticals with additional applications in other sectors. The growing consumer awareness is driving the adoption of phospholipids across multiple industries and contributing to market growth.

North America dominates the global market. The region struggles with a high prevalence of chronic diseases like heart disease and diabetes. According to the Centers for Disease Control and Prevention, 8.9% of US population was diagnosed with diabetes in 2021. Also, about 695,000 people in US died from heart disease in 2021. This necessitates effective treatments, and phospholipids play a crucial role in drug delivery and improving bioavailability, driving its demand in the regional market.

Dynamics

Growing Demand for Phospholipids in Pharmaceutical and Nutraceutical Industries

As chronic diseases like heart disease and diabetes become more prevalent, the demand for effective treatments increases. People are more interested in maintaining good health and creating a market for nutraceutical and pharmaceutical products. The growing focus on preventive healthcare fuels the demand for pharmaceutical and nutraceutical products containing phospholipids which are seen as beneficial for overall health.

Phospholipids help drugs get absorbed better by the body, making them more effective. Many drugs are poorly soluble in water. Phospholipids fix poorly the solubility of certain drugs allowing for better delivery. As the pharmaceutical and nutraceutical sectors continue to expand globally, the demand for phospholipids is expected to rise significantly.

New and Innovative Launches

The new products and technologies introduced into the market increase the exploration and utilisation of phospholipids in various end-use applications with new and accessible utility options, expanding the market growth. For instance, in May 2024, Vitafoods Europe launched MPL+, a marine phospholipid cellular nutrition and innovative product. MPL+ technology platform utilises the potential of phospholipids as a unique delivery platform to bring innovations to the nutraceuticals industry.

Similarly, in November 2022, Aker BioMarine launched a new PL+ technology platform that uses phospholipids from krill to improve the solubility and emulsification of ingredients with poor bioavailability or absorption rates. The PL+ technology comes encapsulated in soft gels with challenging ingredients, such as cannabidiol, curcumin and others. According to Aker BioMarine, PL+ can boost absorption by up to 25 times.

High Costs Associated with Phospholipids

One major hindering factor for the global phospholipids market is the high cost associated with production and extraction processes. Phospholipids aren't easy to get from their natural sources like soybeans or eggs. These complex extraction techniques require expensive equipment, advanced technology and a skilled workforce. Efficient extraction relies on sophisticated technology, adding to the overall cost.

In addition, raw material fluctuations can also add fuel to the higher prices. The cost of soybeans, eggs, or sunflower seeds, the main sources of phospholipids, can change significantly. This instability makes it difficult for producers to predict and manage their overall pricing. This can discourage companies from entering the market and limit the affordability of phospholipid products for consumers.

Segment Analysis

The global phospholipids market is segmented based on type, source, functionality, application and region.

Rising Need for Functional Food and Beverage Products

The global phospholipids market is segmented based on application into food & beverage, nutraceutical supplements, pharmaceuticals and others. The food & beverage segment accounts for the largest share of the global market. The multifunctional properties of phospholipids, coupled with consumer demand for healthier, clean-label food and beverage products, contribute to the dominance of the food and beverage application segment in the global phospholipids market.

People are increasingly prioritizing healthy eating and functional foods that offer additional health benefits. With a growing emphasis on health and wellness, consumers are increasingly seeking out food and beverage products that offer functional benefits. Phospholipids play a crucial role in improving the texture and mouthfeel of food and beverage products.

In the food and beverage industry, phospholipids are widely used emulsifiers in products such as margarine, chocolate, dressings, and beverages to create stable emulsions, improve texture, and enhance mouthfeel. Phospholipids can be added to functional beverages to enhance nutrient delivery, improve stability, and impart health benefits, aligning with consumer preferences for functional and convenient beverage options.

Geographical Penetration

Greater Presence of Phospholipids Utilising Industries in North America

North America dominates the global market with the presence of various leading pharmaceutical and nutraceutical companies that heavily rely on phospholipids for various applications. These industries are at the forefront of research and development, driving demand for innovative phospholipid products. The region's well-established pharmaceutical industry utilizes phospholipids in drug delivery systems and formulations.

Additionally, the region has a robust food and beverage industry, where phospholipids are used as emulsifiers and functional ingredients in a wide range of products. The presence of key market players and research institutions focused on lipid science also contributes to the region's dominance. The region is benefited from the presence of advanced technology and skilled labor, which leads to efficient extraction and processing methods.

Competitive Landscape

The major global players in the market include Cargill, Inc., Archer Daniels Midland Company, Bunge Ltd, Lipoid GmbH, VAV Life Sciences, American Lecithin Company, Kewpie Corporation, Lecico GmbH, Nabros Pharma Pvt. Ltd., and Croda International Plc.

COVID-19 Impact Analysis

The COVID-19 pandemic had both positive and negative impact on the global phospholipids market. During the initial phases of the pandemic, lockdowns, travel restrictions and disruptions in transportation networks led to challenges in the supply chain for raw materials and finished phospholipid products. This resulted in delays in production, procurement difficulties and increased logistics costs for manufacturers and suppliers.

The pandemic altered consumer behaviours and preferences, leading to changes in demand for phospholipid-containing products, due to an increased focus on health and wellness. There was increased demand for certain pharmaceutical formulations and functional foods with immune-boosting ingredients. The pharmaceutical and nutraceutical industries, which are significant consumers of phospholipids, experienced varying impacts, positively impacting the market growth.

By Type

Phosphotidylserine
Phosphotidylcholine
Others

By Source

Soy
Sunflower
Egg
Others

By Functionality

Emulsifying
Wetting & Dispersion
Thickening & Gelling
Nutrient Delivery

By Application

Food & beverage
Nutraceutical Supplements
Pharmaceuticals
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In May 2024, Vitafoods Europe launched MPL+, a marine phospholipid cellular nutrition and innovative product. MPL+ technology platform utilises the potential of phospholipids as a unique delivery platform to bring innovations to the nutraceuticals industry.
In November 2022, Aker BioMarine launched a new PL+ technology platform that uses phospholipids from krill to improve the solubility and emulsification of ingredients with poor bioavailability or absorption rates.
In January 2021, NZMP, a dairy ingredient-solutions brand by global dairy mainstay Fonterra, launched milk phospholipids. Naturally present in milk, these complex lipids are clinically proven to help manage the effects of stress, to allow consumers to stay focused and positive under stress.

Why Purchase the Report?

To visualize the global phospholipids market segmentation based on type, source, functionality, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of phospholipids market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global phospholipids market report would provide approximately 70 tables, 64 figures and 243 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Source
3.3. Snippet by Functionality
3.4. Snippet by Application
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Demand for Phospholipids in Pharmaceutical and Nutraceutical Industries
  - 4.1.1.2. New and Innovative Launches
- 4.1.2. Restraints
  - 4.1.2.1. High Costs Associated with Phospholipids
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Phosphotidylserine
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Phosphotidylcholine
7.4. Others

8. By Source

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 8.1.2. Market Attractiveness Index, By Source
8.2. Soy
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Sunflower
8.4. Egg
8.5. Others

9. By Functionality

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 9.1.2. Market Attractiveness Index, By Functionality
9.2. Emulsifying
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Wetting & Dispersion
9.4. Thickening & Gelling
9.5. Nutrient Delivery

10. By Application

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.1.2. Market Attractiveness Index, By Application
10.2. Food & Beverage
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Nutraceutical Supplements
10.4. Pharmaceuticals
10.5. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Cargill, Inc.
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Archer Daniels Midland Company
13.3. Bunge Ltd.
13.4. Lipoid GmbH
13.5. VAV Life Sciences
13.6. American Lecithin Company
13.7. Kewpie Corporation
13.8. Lecico GmbH
13.9. Nabros Pharma Pvt. Ltd.
13.10. Croda International Plc.

LIST NOT EXHAUSTIVE